With Soriot out, Roche taps O'Day to lead pharma business

Roche ($RHHBY) pharma chief Pascal Soriot's departure for AstraZeneca ($AZN) triggered a bit of musical chairs at the Swiss drugmaker. Daniel O'Day, who's been COO of Roche Diagnostics, will take the helm at Roche Pharma, and Roland Diggelmann will move up to take O'Day's place. Release | Report